Stukova МА, Rydlovskaya AV, Proskurina OV, Mochalov SV, Shurygina AS, Nebolsin VE. <em>In vitro</em> and <em>in vivo</em> pharmacodynamic activity of the new compound XC221GI in models of the viral inflammation of the respiratory tract. jour 2022;9:56-70. [DOI: 10.18527/2500-2236-2022-9-1-56-70][Cited by in F6Publishing: 1][Reference Citation Analysis]
Number
Citing Articles
1
Gorelov AV, Kalyuzhin OV, Bagaeva MI. New opportunities for preventive anti-inflammatory therapy in the management of patients with moderate and severe COVID-19. Terapevticheskii arkhiv 2022;94:872-875. [DOI: 10.26442/00403660.2022.07.201729][Reference Citation Analysis]